Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Beactica Therapeutics AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 8,701 Less Arrow 7,385 Less Arrow 7,341
Financial expenses 77 More Arrow 110 Less Arrow 109
Earnings before taxes -4,914 Less Arrow -9,019 Less Arrow -10,651
EBITDA -4,901 Less Arrow -8,742 Less Arrow -10,340
Total assets 32,175 Less Arrow 29,972 More Arrow 36,506
Current assets 5,345 Less Arrow 4,276 More Arrow 12,875
Current liabilities 2,362 More Arrow 2,368 More Arrow 4,322
Equity capital 29,813 Less Arrow 27,118 More Arrow 31,135
- share capital 388 Less Arrow 358 Less Arrow 337
Employees (average) 6 More Arrow 9 Less Arrow 8

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 92.7% Less Arrow 90.5% Less Arrow 85.3%
Turnover per employee 1,450 Less Arrow 821 More Arrow 918
Profit as a percentage of turnover -56.5% Less Arrow -122.1% Less Arrow -145.1%
Return on assets (ROA) -15.0% Less Arrow -29.7% More Arrow -28.9%
Current ratio 226.3% Less Arrow 180.6% More Arrow 297.9%
Return on equity (ROE) -16.5% Less Arrow -33.3% Less Arrow -34.2%
Change turnover 1,316 Less Arrow 44 More Arrow 2,872
Change turnover % 18% Less Arrow 1% More Arrow 64%
Chg. No. of employees -3 More Arrow 1 Less Arrow 0
Chg. No. of employees % -33% More Arrow 13% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.